Association between the triglyceride-glucose index in third trimester pregnant women and neonatal birth weight

Jialei Shen1, Wenhui Liu2, Kedan Cao3

  • 1Department of Obstetrics and Gynecology, Changzhou Maternal and Child Health Care Hospital, Changzhou, China. sjlfish@163.com.

Ginekologia Polska
|March 27, 2025
PubMed

Insights

The triglyceride-glucose (TYG) index in late pregnancy positively correlates with neonatal birth weight. Higher TYG index values are linked to increased infant weight, suggesting its potential as a predictive marker.

Area of Science:

  • Reproductive Medicine
  • Metabolic Health
  • Neonatal Development

Background:

  • Neonatal birth weight is critical for infant health and development.
  • The triglyceride-glucose (TYG) index reflects maternal insulin resistance and metabolic status.
  • Maternal metabolic health significantly influences fetal growth.

Purpose of the Study:

  • To investigate the association between the maternal triglyceride-glucose (TYG) index in the third trimester and neonatal birth weight.
  • To determine if the TYG index can serve as a predictive biomarker for fetal growth.

Main Methods:

  • A cohort of 475 neonates and their mothers was studied.
  • Maternal TYG index was calculated in the third trimester.
  • Correlation and multivariate regression analyses were used to assess the association with neonatal birth weight.

Main Results:

  • A significant positive correlation was found between the TYG index and neonatal birth weight (r=0.314, p<0.001).
  • Each increment in TYG index was associated with a 227.22g increase in neonatal weight.
  • The association was stronger in mothers without gestational diabetes, in male neonates, and in mothers over 31.

Conclusions:

  • The TYG index in the third trimester is a significant positive predictor of neonatal birth weight.
  • The TYG index may be a valuable tool for predicting fetal growth and managing pregnancy.
  • Stronger associations in specific subgroups highlight potential targeted applications.
Abstract

Related Concept Videos

Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
833
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.1K
Glucose Transporters01:27

Glucose Transporters

Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
22.3K
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
353
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
143